series-a
Stage
About
Kyverna Therapeutics is developing novel therapies targeting autoimmune and inflammatory diseases by advancing regulatory T cell (Treg) therapies.
Explore Kyverna Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.